Puma Venture Capital has significantly enhanced its leadership team with the appointment of two distinguished industry veterans, Fred Moll and Scott Zinober, as new Partners. This strategic move fortifies the firm's investment platform, which operates at the intersection of medical technology, robotics, and healthcare innovation. The addition of Moll and Zinober signals Puma VC's deepened commitment to identifying and nurturing transformative companies in the medtech sector.
A Strategic Expansion of Expertise
According to Amit Hazan, Founder and Managing Partner of Puma VC, the new partners embody two complementary strengths crucial for building an enduring venture platform. Moll brings world-class medtech entrepreneurship, while Zinober contributes decades of disciplined healthcare investing experience. Their combined perspectives are expected to sharpen the firm's diligence, expand its network, and strengthen its support for founders navigating product development and commercial scaling.
The Visionary Behind Modern Surgical Robotics
Dr. Fred Moll is widely recognized as a pioneering force in the field of surgical robotics and early-stage medical technology. He is best known as a co-founder of Intuitive Surgical, where he was instrumental in developing the groundbreaking da Vinci surgical system. His entrepreneurial success continued with the founding of Auris Health, creator of the Monarch robotic platform, which was later acquired by Johnson & Johnson.
An Elite Healthcare Investment Strategist
Scott Zinober joins the firm with over two decades of experience as a leading healthcare investor. During his tenure as a Senior Portfolio Manager at Viking Global Investors, he managed a multi-billion dollar portfolio spanning various healthcare sectors and also led the firm's software team. His leadership extended to serving on Viking’s investment steering committee and management committee for more than a decade.
Bolstering a Clinician-Centric Approach
Puma VC's investment strategy is uniquely anchored in deep domain expertise, reinforced by a network of more than 20 surgeon venture partners. These key opinion leaders and innovators provide invaluable clinical diligence, workflow insights, and commercialization guidance throughout a portfolio company's lifecycle. This surgeon-led model ensures that investments are grounded in real-world medical needs and applications.
Dr. Vipul Patel, Co-Founder and Senior Surgeon Venture Partner, emphasized that success in healthcare robotics depends on earning trust in the operating room and integrating into clinical workflows. He stated that the addition of Moll and Zinober enhances the firm's ability to evaluate what truly matters in medical innovation. Their expertise will help founders build solutions that can scale responsibly and effectively within the complex healthcare environment.
The appointments of Fred Moll and Scott Zinober mark a significant milestone for Puma Venture Capital, substantially strengthening its capabilities in the competitive medtech landscape. By combining pioneering entrepreneurial vision with seasoned investment acumen, the firm is better positioned to drive the next wave of innovation in healthcare robotics. This strategic enhancement underscores Puma VC's dedication to supporting companies that are shaping the future of medicine.